| scholarly article | Q13442814 |
| P50 | author | Ju Wang | Q49870866 |
| P2093 | author name string | Ying Hu | |
| Feng Cheng | |||
| Yichen Yang | |||
| Zhonghai Fang | |||
| Dekai Rohlsen-Neal | |||
| P2860 | cites work | A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors | Q22251463 |
| Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice | Q24338349 | ||
| Computing topological parameters of biological networks | Q51900389 | ||
| Cytoscape: Software for Visualization and Analysis of Biological Networks | Q56519280 | ||
| Guilt-by-association goes global | Q59048545 | ||
| Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers | Q72692433 | ||
| Mutation and association analysis of the Fyn kinase gene with alcoholism and schizophrenia | Q73307572 | ||
| The synapse: center stage for many brain diseases | Q82927794 | ||
| Effect of COMT Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia | Q87128625 | ||
| PINA v2.0: mining interactome modules. | Q35630696 | ||
| Cortical opioid markers in schizophrenia and across postnatal development | Q35894118 | ||
| Src in synaptic transmission and plasticity | Q35920905 | ||
| Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk | Q35945297 | ||
| Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia | Q36141781 | ||
| Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia. | Q36561214 | ||
| Glutamate and dopamine components in schizophrenia. | Q37409209 | ||
| Protein-Protein Interaction and Pathway Analyses of Top Schizophrenia Genes Reveal Schizophrenia Susceptibility Genes Converge on Common Molecular Networks and Enrichment of Nucleosome (Chromatin) Assembly Genes in Schizophrenia Susceptibility Loci | Q37451468 | ||
| Molecular networks as sensors and drivers of common human diseases | Q37594580 | ||
| Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings | Q38124448 | ||
| Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach | Q38472884 | ||
| Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review | Q39131293 | ||
| Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls | Q39372058 | ||
| Smoking and mental illness: A population-based prevalence study | Q39513259 | ||
| Genetic correlation between smoking behaviors and schizophrenia | Q40296328 | ||
| The dopamine hypothesis of schizophrenia. | Q41213889 | ||
| Dopamine, the prefrontal cortex and schizophrenia | Q41518710 | ||
| Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia | Q41667137 | ||
| A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case | Q42567659 | ||
| Acute Nicotine Alteration of Sensory Memory Impairment in Smokers With Schizophrenia | Q42918760 | ||
| Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia | Q43067774 | ||
| Substance use disorders in schizophrenia--clinical implications of comorbidity | Q43145195 | ||
| Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia | Q43422573 | ||
| Rapid synaptic remodeling by protein kinase C: reciprocal translocation of NMDA receptors and calcium/calmodulin-dependent kinase II. | Q43918824 | ||
| Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia | Q44133505 | ||
| A serotonin hypothesis of schizophrenia | Q46521982 | ||
| Effects of nicotine nasal spray on cognitive function in schizophrenia | Q46701596 | ||
| Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. | Q46881158 | ||
| Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity | Q47614245 | ||
| The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services | Q47743486 | ||
| Tobacco smoking and its association with cognition in first episode psychosis patients. | Q47747784 | ||
| Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia | Q48212243 | ||
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks | Q24570122 | ||
| Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing | Q24570129 | ||
| Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease | Q24644398 | ||
| Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness | Q26849474 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Nicotinic ACh receptors as therapeutic targets in CNS disorders | Q28111941 | ||
| Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
| Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7) | Q28203593 | ||
| Nicotine use in schizophrenia: the self medication hypotheses | Q28257325 | ||
| Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia | Q28274064 | ||
| Pathways and networks-based analysis of candidate genes associated with nicotine addiction | Q28547199 | ||
| Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release | Q28591015 | ||
| Schizophrenia. | Q30251961 | ||
| nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. | Q30362464 | ||
| Smoking in schizophrenic patients: A critique of the self-medication hypothesis | Q30416030 | ||
| Ras and Rap signaling in synaptic plasticity and mental disorders | Q30431817 | ||
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation | Q30435362 | ||
| New insights into the genetics of addiction | Q30435949 | ||
| Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction | Q30491854 | ||
| Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases | Q30943588 | ||
| Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes | Q33586386 | ||
| SZGR: a comprehensive schizophrenia gene resource | Q33819217 | ||
| Addiction and schizophrenia | Q33958615 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence. | Q34200260 | ||
| The association between schizophrenia and cigarette smoking: a review of the literature and implications for mental health nursing practice | Q34227972 | ||
| Lifetime prevalence of psychotic and bipolar I disorders in a general population | Q34596831 | ||
| The Glutamatergic Dysfunction Hypothesis for Schizophrenia | Q34743689 | ||
| Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits | Q35048154 | ||
| Roles of dopamine signaling in nicotine addiction | Q35093251 | ||
| Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder | Q35196495 | ||
| Disease networks. Uncovering disease-disease relationships through the incomplete interactome | Q35619320 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 2894 | |
| P577 | publication date | 2018-02-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach | |
| P478 | volume | 8 |
| Q89505177 | Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors |
| Q92058120 | Patient-Informed Treatment Development of Behavioral Smoking Cessation for People With Schizophrenia |
| Q64114752 | Quantitative Systems Pharmacological Analysis of Drugs of Abuse Reveals the Pleiotropy of Their Targets and the Effector Role of mTORC1 |
| Q90666112 | Use of tobacco in schizophrenia: A double-edged sword |
Search more.